How much funding has Trivascular raised?

Trivascular has raised $267.8M in total funding, most recently a Series E round.

Who are Trivascular's investors?

Trivascular's investors include New Enterprise Associates, MPM Capital, Kaiser Permanente Ventures, ABS Capital Partners, Delphi Ventures, The Vertical Group.

When was Trivascular founded?

Trivascular was founded in 1999.

Where is Trivascular headquartered?

Trivascular is headquartered in Santa Rosa, California, United States.

What industry is Trivascular in?

Trivascular operates in Biotech, Medical Devices.

How many employees does Trivascular have?

Trivascular has 201-500 employees.

Trivascular

Merged

Embrace the evidence

Santa Rosa, United States · Founded 1999 · $267.8M raised

Biotech

Medical Devices

Headquarters: Santa Rosa, California
Employees: 201–500
Founded: 1999
Business Model: B2B

Website: trivascular.com
Total Funding: $267.8M
Last Round: $40.0M Series ENov 2013
Rounds: 7

About

TriVascular, now part of Endologix, develops endovascular aneurysm repair (EVAR) solutions for abdominal aortic aneurysms. They pioneered technologies for optimal patient outcomes in vascular disease, including the DETOUR System. Focused on disruptive innovation, clinical evidence, and physician training with VR.

Summary

Trivascular is a Biotech company based in Santa Rosa, United States, founded in 1999. It has raised $267.8M in total across 7 rounds, most recently a $40.0M Series E round in Nov 2013. Investors include New Enterprise Associates, MPM Capital and Kaiser Permanente Ventures.

LinkedIn X (Twitter)